AZ-6102

N/A

Report date: 2025/01/26 17:46:58
NME

Base Information

Drug NameAZ-6102
Drug Alias Nametankyrase 1/2 inhibitors (AstraZeneca)AZ-6102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTankyrase-1 inhibitorsTankyrase-2 inhibitors
TargetsTankyrase-2Tankyrase-1
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Pharmaceuticals Lp
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Pharmaceuticals Lp
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A